Mark Cuban Praises TrumpRx Deal With Eli Lilly, Novo Nordisk
When President Trump told an audience in October that he hoped to cut the cost of Ozempic down…
Is Eli Lilly a Millionaire Maker?
Eli Lilly’s GLP-1 drug portfolio should power the business for at least the next decade. But the market…
Massive sales for weight loss drugs spur Eli Lilly’s Q3
As weight loss market rival Novo Nordisk drew headlines for starting a bidding war over a potential $9bn…
Eli Lilly says weight-loss pill a candidate for speedy approval under new US program
By Mrinalika Roy and Patrick Wingrove (Reuters) -Eli Lilly said on Thursday its experimental weight-loss pill met most…
Walmart, Eli Lilly to Offer Pickup for Zepbound With D2C Pricing
Consumers will soon be able to pick up single-dose vials of the weight loss drug Zepbound at Walmart…
What To Know About President Trump’s Cognitive Test
In this week’s edition of InnovationRx, we look at President Trump’s cognitive test, Nvidia’s collaborations in life sciences…
Radiopharmaceuticals Market to Reach US$ 13.4 Billion by 2033
AstuteAnalytica India Pvt. Ltd. Surging multibillion dollar acquisitions and a pipeline of innovative therapies define the current landscape.…
Trump’s $150 Ozempic? Oz cautions it’s not a done deal, but patients and doctors say it could be a gamechanger
Janet McCaskill was on vacation in Arizona with her husband and best friend when she heard that President…
Trump’s $150 Ozempic? Oz cautions it’s not a done deal, but patients and doctors say it could be a gamechanger
Janet McCaskill was on vacation in Arizona with her husband and best friend when she heard that President…
Morning Business Report: Mortgage rates dip as housing market cools; stocks, drugmakers fall amid tariff pressures 41NBC News
There’s a bit of relief for potential homebuyers this week. (LILAMAX)- There’s a bit of relief for potential…
LLY’s Oral GLP-1 Pill Scores Another Pair of Diabetes Wins
Eli Lilly LLY announced positive top-line data from two late-stage studies evaluating orforglipron, its once-daily oral GLP-1 pill, in…
Ex-FDA regulator Peter Marks joins Eli Lilly
WASHINGTON — Peter Marks, the former top vaccine regulator at the Food and Drug Administration, has joined Eli Lilly…